Literature DB >> 29427782

Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism.

Ruoxin Zhang1, Jinlong Zhou2, Junrong Ren2, Siqi Sun2, Yuanyuan Di2, Hanyu Wang2, Xiaoqin An2, Kexin Zhang2, Junfeng Zhang3, Zhaoqiang Qian4, Meimei Shi4, Yanning Qiao4, Wei Ren4, Yingfang Tian5.   

Abstract

Gene-environmental interaction could be the major cause of autism. The aim of the current study is to detect the effects of valproic acid on gene expression profiles and alternatively spliced genes in the prefrontal cortex in rat models of autism. Female rats received a single intraperitoneal injection of 600 mg/kg valproic acid at day 12.5 post-conception, and controls were injected with saline. Only male offspring were employed in the current study. RNA sequencing was used to investigate transcriptome in the prefrontal cortex of VPA-exposed rats. There were 3228 differently expressed genes and 637 alternative spliced genes, in VPA rats compared to controls. Pathways enrichment among the differently expressed genes and alternatively spliced genes were associated with neurological diseases and neural system development. The results implied VPA affected transcriptional and splicing events genome-wide and the transcriptional and splicing events may be associated with the autistic behaviors of VPA rats.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing gene; Autism; RNA sequencing (RNA-seq); Transcriptome; Valproic acid (VPA)

Mesh:

Substances:

Year:  2018        PMID: 29427782     DOI: 10.1016/j.reprotox.2018.01.008

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  8 in total

1.  Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity.

Authors:  Soham Chanda; Cheen Euong Ang; Qian Yi Lee; Michael Ghebrial; Daniel Haag; Yohei Shibuya; Marius Wernig; Thomas C Südhof
Journal:  Cell Stem Cell       Date:  2019-05-30       Impact factor: 24.633

2.  Altered Developmental Trajectory in Male and Female Rats in a Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder.

Authors:  Kumari Anshu; Ajay Kumar Nair; Shoba Srinath; T Rao Laxmi
Journal:  J Autism Dev Disord       Date:  2022-08-17

Review 3.  Role of Microtubule-Associated Protein in Autism Spectrum Disorder.

Authors:  Qiaoqiao Chang; Hua Yang; Min Wang; Hongen Wei; Fengyun Hu
Journal:  Neurosci Bull       Date:  2018-06-23       Impact factor: 5.203

4.  Gene Expression Profiling Analysis Reveals Putative Phytochemotherapeutic Target for Castration-Resistant Prostate Cancer.

Authors:  Solomon Oladapo Rotimi; Oluwakemi Anuoluwapo Rotimi; Abdulkadir Ayo Salako; Paul Jibrin; Jelili Oyelade; Emeka E J Iweala
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

5.  Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA).

Authors:  Liza Weinstein-Fudim; Zivanit Ergaz; Moshe Szyf; Asher Ornoy
Journal:  Int J Mol Sci       Date:  2020-04-18       Impact factor: 5.923

6.  Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model.

Authors:  Veronika Bódi; Tímea Májer; Viktor Kelemen; Ildikó Világi; Attila Szűcs; Petra Varró
Journal:  Front Neural Circuits       Date:  2022-02-04       Impact factor: 3.492

7.  RNA-Seq data on prefrontal cortex in valproic acid model of autism and control rats.

Authors:  Zhaoqiang Qian; Ruoxin Zhang; Jinlong Zhou; Siqi Sun; Yuanyuan Di; Wei Ren; Yingfang Tian
Journal:  Data Brief       Date:  2018-03-21

8.  Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?

Authors:  Liza Weinstein-Fudim; Zivanit Ergaz; Gadi Turgeman; Joseph Yanai; Moshe Szyf; Asher Ornoy
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.